Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS).
Kasuya G, Terashima K, Shibuya K, Toyama S, Ebner DK, Tsuji H, Okimoto T, Ohno T, Shioyama Y, Nakano T, Kamada T; Japan Carbon-Ion Radiation Oncology Study Group. Kasuya G, et al. Among authors: toyama s. Oncotarget. 2019 Jul 9;10(43):4369-4379. doi: 10.18632/oncotarget.27028. eCollection 2019 Jul 9. Oncotarget. 2019. PMID: 31320991 Free PMC article.
Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma.
Toyama S, Tsuji H, Mizoguchi N, Nomiya T, Kamada T, Tokumaru S, Mizota A, Ohnishi Y, Tsujii H; Working Group for Ophthalmologic Tumors. Toyama S, et al. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):270-6. doi: 10.1016/j.ijrobp.2012.12.022. Epub 2013 Feb 13. Int J Radiat Oncol Biol Phys. 2013. PMID: 23414768
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.
Nomiya T, Tsuji H, Maruyama K, Toyama S, Suzuki H, Akakura K, Shimazaki J, Nemoto K, Kamada T, Tsujii H; Working Group for Genitourinary Tumors. Nomiya T, et al. Among authors: toyama s. Br J Cancer. 2014 May 13;110(10):2389-95. doi: 10.1038/bjc.2014.191. Epub 2014 Apr 10. Br J Cancer. 2014. PMID: 24722181 Free PMC article. Clinical Trial.
Particle radiotherapy for prostate cancer.
Shioyama Y, Tsuji H, Suefuji H, Sinoto M, Matsunobu A, Toyama S, Nakamura K, Kudo S. Shioyama Y, et al. Among authors: toyama s. Int J Urol. 2015 Jan;22(1):33-9. doi: 10.1111/iju.12640. Epub 2014 Oct 12. Int J Urol. 2015. PMID: 25308767 Review.
A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T, Tsuji H, Kawamura H, Ohno T, Toyama S, Shioyama Y, Nakayama Y, Nemoto K, Tsujii H, Kamada T. Nomiya T, et al. Among authors: toyama s. Radiother Oncol. 2016 Nov;121(2):288-293. doi: 10.1016/j.radonc.2016.10.009. Epub 2016 Nov 9. Radiother Oncol. 2016. PMID: 27836119 Free article.
422 results